SUNSHINE PHARMA

Sunshine Lake Pharma Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology. It offers Kewei for the treatment of influenza; Dongweien and Dongyinghe for the treatment of hepatitis C. The company also engages in the import, export, wholesale, retail, and distribution of pharmaceutical products, intermediates, and active pharmaceutical ingredients; product quality inspection; research and development of biosimilar drugs and new biologic; research and production of generic drug; pharmaceutical information consultation, analysis and investigation and pharmaceutical market promotion; and research, development production, and sales of chemical raw material drugs and chemical preparations.